Davy James, Managing Editor

BRAF mutations commonly found in melanoma also seen in subset of lung cancer patients.

Merck's once-daily treatment regimen of grazoprevir and elbasvir may bring added competition to HCV drug market.

Introduction of protein to pancreatic cancer cells causes them to revert back to normal.

Gene may help identify clue to separation of overactive and underactive immune activity.

Nearly 30% of total biologic drug costs paid out-of-pocket.

Taking over-the-counter supplements beyond the recommended amount could increase cancer risk.

Suppression of Wnt signaling pathway shows promise.

Long term implications result when patients stop taking disease-modifying drugs.

An antiviral and anti-cancer drug combination was 100% effective in preclinical trials.

Top stories of the week on Specialty Pharmacy Times from April 20 to April 24.

Wiskott-Aldrich treatment shows robust clinical effect.

Re-engineering antibodies allows them to selectively kill tumors.

Catamaran chief medical officer discusses various trends that will impact specialty medications into the future.

Topical medications that treat skin conditions prompt stem cells in the brain to repair damage.

Regulating PD-L1 protein that helps cancer evade immune system suggests new therapeutic approach.

Patients should be counseled that there is no safe level of alcohol consumption.

Novel pathway regulating immune cell movement may help eliminate debilitating effects of several serious diseases.

Pushing treatment with natalizumab from 4 weeks up to 8 weeks shows promising results.

Researchers determine mechanism for poor survival rates in African American patients with estrogen-receptor positive breast cancer.

Mild exercise found to improve fatigue and depression.

Medication also used in treatment of Crohn's disease effective at blocking pathways.

Mild cognitive impairment can set in prior to the start of therapy.

Record number of orphan drugs approved in 2014.

Phenytoin helps to reduce damage to the nerve fiber.

Itraconazole shows some promise in treatment of metastatic prostate cancer.

Orphan drugs and breakthrough therapies last year comprised the highest number of new medications approved since 2001.

Mortality gap in cancer deaths among African Americans and Caucasians may eventually disappear.

Treatment found to improve several measures of disease activity and quality of life in patients with Behçet's disease.

Study suggests substances in synthetic marijuana may damage human cell DNA.

Researchers find biological evidence of repaired myelin.